BioCryst Pharmaceuticals
BCRX
#4928
Rank
โ‚น183.89 B
Marketcap
โ‚น714.72
Share price
-1.04%
Change (1 day)
12.00%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -โ‚น103.08

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น135.24. In 2022 the company made an earnings per share (EPS) of -โ‚น124.91 a decrease over its 2021 EPS that were of -โ‚น96.74.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น103.08-17.48%
2022-โ‚น124.9129.13%
2021-โ‚น96.74-4.63%
2020-โ‚น101.4310.2%
2019-โ‚น92.040%
2018-โ‚น92.0425.64%
2017-โ‚น73.264%
2016-โ‚น70.4427.12%
2015-โ‚น55.41-13.24%
2014-โ‚น63.8623.64%
2013-โ‚น51.65-30.38%
2012-โ‚น74.20-37.3%
2011-โ‚น118.3465.79%
2010-โ‚น71.38117.14%
2009-โ‚น32.87-46.15%
2008-โ‚น61.05-26.97%
2007-โ‚น83.59-40.67%
2006-โ‚น140.8848.51%
2005-โ‚น94.861%
2004-โ‚น93.9238.89%
2003-โ‚น67.62-25%
2002-โ‚น90.16231.03%
2001-โ‚น27.24-56.72%
2000-โ‚น62.9391.43%
1999-โ‚น32.872.94%
1998-โ‚น31.93-55.84%
1997-โ‚น72.3211.59%
1996-โ‚น64.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น291.15 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น270.23-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น247.00 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.78-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น142.76 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.54 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น41.32-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น298.66 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น323.08 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA